Importantly, most side effects occur during dose escalation and tend to improve over time
Summary Keywords antioxidant, bronchiectasis, COPD, cystic fibrosis, mucolytic, N-acetylcysteine Citation Barne M, Shevade M, Bhattacharyya P, Christopher DJ, Nair S, Abhyankar N, Halder I, Vora A, Khanna A, Swarnakar R, Chhajed P, Santhalingam B, Nair A and Salvi S (2026) N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR)
Graphene composite ink promises to be an excellent choice for making sensing electrodes, due to its simplicity and low cost
doi:10.1016/j.tox.2010.02.006 Marin S, Ramos AJ, Cano-Sancho G, Sanchis V
Neurodegenerative diseases and Withania somnifera (L.): an update